Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS) Meeting Abstract
| Authors: | Hartner, L. P.; Rosen, L.; Hensley, M.; Mendelson, D.; Staddon, A. P.; Chow, W.; Kovalyov, O.; Ruka, W.; Skladowski, K.; Jagiello-Gruszfeld, A.; Byakhov, M. |
| Abstract Title: | Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 727s |
| Language: | English |
| ACCESSION: | WOS:000455043705189 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.20521 |
| Notes: | Meeting Abstract: 20521 -- Source: Wos |
